Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damage

Toxicology Reports

Volumn 1, Issue , 2014, Pages 309-318

  Dhillon, Harsharan ^a   Chikara, Shireen ^a   Reindl, Katie M ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Natural products; Pancreatic cancer; ROS

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; DICHLORODIHYDROFLUORESCEIN DIACETATE; GLUTATHIONE TRANSFERASE P1; HEME OXYGENASE 1; KI 67 ANTIGEN; PIPERLONGUMINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL BEHAVIOR ASSAY; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DNA DAMAGE; DNA FRAGMENTATION ASSAY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; ORGAN WEIGHT; OXIDATIVE STRESS; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SPECTROPHOTOMETRY; TUMOR GROWTH; TUMOR XENOGRAFT; WESTERN BLOTTING;

EID: 84919486388     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2014.05.011     Document Type: Article

References (24)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J. Clin. 2013, 63:11-30.
2. Heinemann V., Boeck S. Perioperative management of pancreatic cancer. Ann. Oncol. 2008, 19(Suppl. 7):vii273-vii278.
3. Stathis A., Moore M.J. Advanced pancreatic carcinoma: current treatment and future challenges. Nat. Rev. Clin. Oncol. 2010, 7:163-172.
4. Qanungo S., Das M., Haldar S., Basu A. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 2005, 26:958-967.
5. Zhang R., Humphreys I., Sahu R.P., Shi Y., Srivastava S.K. In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway. Apoptosis 2008, 13:1465-1478.
6. Jutooru I., Chadalapaka G., Lei P., Safe S. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. J. Biol. Chem. 2010, 285:25332-25344.
7. Fruehauf J.P., Meyskens F.L. Reactive oxygen species: a breath of life or death?. Clin. Cancer Res. 2007, 13:789-794.
8. Pelicano H., Carney D., Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist. Updat. 2004, 7:97-110.
9. Ough M., Lewis A., Bey E.A., Gao J., Ritchie J.M., Bornmann W., Boothman D.A., Oberley L.W., Cullen J.J. Efficacy of beta-lapachone in pancreatic cancer treatment: exploiting the novel, therapeutic target NQO1. Cancer Biol. Therapy 2005, 4:95-102.
10. Li L.S., Bey E.A., Dong Y., Meng J., Patra B., Yan J., Xie X.J., Brekken R.A., Barnett C.C., Bornmann W.G., Gao J., Boothman D.A. Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of beta-lapachone for pancreatic cancer therapy. Clin. Cancer Res. 2011, 17:275-285.
11. Cohen S.J., Zalupski M.M., Modiano M.R., Conkling P., Patt Y.Z., Davis P., Dorr R.T., Boytim M.L., Hersh E.M. A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer. Cancer Chemother. Pharmacol. 2010, 66:287-294.
12. Dorr R.T., Raymond M.A., Landowski T.H., Roman N.O., Fukushima S. Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines. Int. J. Gastrointest. Cancer 2005, 36:15-28.
13. Raj L., Ide T., Gurkar A.U., Foley M., Schenone M., Li X., Tolliday N.J., Golub T.R., Carr S.A., Shamji A.F., Stern A.M., Mandinova A., Schreiber S.L., Lee S.W. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011, 475:231-234.
14. Randhawa H., Kibble K., Zeng H., Moyer M.P., Reindl K.M. Activation of ERK signaling and induction of colon cancer cell death by piperlongumine. Toxicol. In Vitro 2013, 27:1626-1633.
15. Renschler M.F. The emerging role of reactive oxygen species in cancer therapy. Eur. J. Cancer 2004, 40:1934-1940.
16. Shankar S., Suthakar G., Srivastava R.K. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer. Front. Biosci. J. Virtual Library 2007, 12:5039-5051.
17. Sahu R.P., Batra S., Srivastava S.K. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Br. J. Cancer 2009, 100:1425-1433.
18. Kim S.T., Lim do H., Jang K.T., Lim T., Lee J., Choi Y.L., Jang H.L., Yi J.H., Baek K.K., Park S.H., Park Y.S., Lim H.Y., Kang W.K., Park J.O. Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy. Mol. Cancer Ther. 2011, 10:1993-1999.
19. Pao W., Wang T.Y., Riely G.J., Miller V.A., Pan Q., Ladanyi M., Zakowski M.F., Heelan R.T., Kris M.G., Varmus H.E. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. PLoS Med. 2005, 2:e17.
20. Massarelli E., Varella-Garcia M., Tang X., Xavier A.C., Ozburn N.C., Liu D.D., Bekele B.N., Herbst R.S., Wistuba I.I. KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. Clin. Cancer Res. 2007, 13:2890-2896.
21. Dickinson B.C., Chang C.J. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat. Chem. Biol. 2011, 7:504-511.
22. Surova O.Z.B. Various modes of cell death induced by DNA damage. Oncogene 2013, 32:3789-3797.
23. Hsieh R.H., Lien L.M., Lin S.H., Chen C.W., Cheng H.J., Cheng H.H. Alleviation of oxidative damage in multiple tissues in rats with streptozotocin-induced diabetes by rice bran oil supplementation. Ann. N. Y. Acad. Sci. 2005, 1042:365-371.
24. Valavanidis A., Vlachogianni T., Fiotakis C. 8-Hydroxy-2'-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health C: Environ. Carcinogen. Ecotoxicol. Rev. 2009, 27:120-139.